Quest Diagnostics Lifts Guidance on Organic Growth

Dow Jones

10/21

By Dean Seal

Quest Diagnostics raised its profit and revenue outlook for the year after strong organic growth and acquisitions boosted its top and bottom lines in the third quarter.

The provider of diagnostic information services said Tuesday that organic revenue growth in the latest completed quarter hit 6.8%, while acquisitions boosted the top line higher.

Quest is now guiding for $10.96 billion to $11 billion in revenue for 2025, up from a prior outlook for $10.8 billion to $10.92 billion, and adjusted earnings of $9.76 to $9.84 a share, up from $9.63 to $9.83 a share.

Shares advanced 2.4% to $195 in premarket trading.

For the third quarter, the Secaucus, N.J., company posted a profit of $245 million, or $2.16 a share, compared with $226 million, or $1.99 a share, in the same quarter a year earlier.

Stripping out one-time items, adjusted earnings were $2.60 a share, topping analyst forecasts by a dime, according to FactSet.

Revenue jumped 13% to $2.82 billion, ahead of analyst estimates for $2.74 billion.

During the quarter, Quest completed the acquisition of select dialysis testing assets from Fresenius Medical Care and separately began to scale clinical lab testing for Fresenius Medical Care's U.S. dialysis customers.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

October 21, 2025 07:12 ET (11:12 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2577182458"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2577182458\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2577182458?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-21 19:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577182458","market":"hk","top_or_hot":-1,"title":"Quest Diagnostics Lifts Guidance on Organic Growth","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Dean Seal \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Quest Diagnostics raised its profit and revenue outlook for the year after strong organic growth and acquisitions boosted its top and bottom lines in the third quarter. \n</p>\n<p>\n  The provider of diagnostic information services said Tuesday that organic revenue growth in the latest completed quarter hit 6.8%, while acquisitions boosted the top line higher. \n</p>\n<p>\n  Quest is now guiding for $10.96 billion to $11 billion in revenue for 2025, up from a prior outlook for $10.8 billion to $10.92 billion, and adjusted earnings of $9.76 to $9.84 a share, up from $9.63 to $9.83 a share. \n</p>\n<p>\n  Shares advanced 2.4% to $195 in premarket trading. \n</p>\n<p>\n  For the third quarter, the Secaucus, N.J., company posted a profit of $245 million, or $2.16 a share, compared with $226 million, or $1.99 a share, in the same quarter a year earlier. \n</p>\n<p>\n  Stripping out one-time items, adjusted earnings were $2.60 a share, topping analyst forecasts by a dime, according to FactSet. \n</p>\n<p>\n  Revenue jumped 13% to $2.82 billion, ahead of analyst estimates for $2.74 billion. \n</p>\n<p>\n  During the quarter, Quest completed the acquisition of select dialysis testing assets from Fresenius Medical Care and separately began to scale clinical lab testing for Fresenius Medical Care's U.S. dialysis customers. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 21, 2025 07:12 ET (11:12 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Quest Diagnostics Lifts Guidance on Organic Growth</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nQuest Diagnostics Lifts Guidance on Organic Growth\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-10-21 19:12</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Dean Seal \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Quest Diagnostics raised its profit and revenue outlook for the year after strong organic growth and acquisitions boosted its top and bottom lines in the third quarter. \n</p>\n<p>\n  The provider of diagnostic information services said Tuesday that organic revenue growth in the latest completed quarter hit 6.8%, while acquisitions boosted the top line higher. \n</p>\n<p>\n  Quest is now guiding for $10.96 billion to $11 billion in revenue for 2025, up from a prior outlook for $10.8 billion to $10.92 billion, and adjusted earnings of $9.76 to $9.84 a share, up from $9.63 to $9.83 a share. \n</p>\n<p>\n  Shares advanced 2.4% to $195 in premarket trading. \n</p>\n<p>\n  For the third quarter, the Secaucus, N.J., company posted a profit of $245 million, or $2.16 a share, compared with $226 million, or $1.99 a share, in the same quarter a year earlier. \n</p>\n<p>\n  Stripping out one-time items, adjusted earnings were $2.60 a share, topping analyst forecasts by a dime, according to FactSet. \n</p>\n<p>\n  Revenue jumped 13% to $2.82 billion, ahead of analyst estimates for $2.74 billion. \n</p>\n<p>\n  During the quarter, Quest completed the acquisition of select dialysis testing assets from Fresenius Medical Care and separately began to scale clinical lab testing for Fresenius Medical Care's U.S. dialysis customers. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 21, 2025 07:12 ET (11:12 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1854103824.USD","symbol_name":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) INC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2577182458","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577182458","pubTimestamp":1761045120,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Quest Diagnostics raised its profit and revenue outlook for the year after strong organic growth and acquisitions boosted its top and bottom lines in the third quarter.The provider of diagnostic information services said Tuesday that organic revenue growth in the latest completed quarter hit 6.8%, while acquisitions boosted the top line higher.Quest is now guiding for $10.96 billion to $11 billion in revenue for 2025, up from a prior outlook for $10.8 billion to $10.92 billion, and adjusted earnings of $9.76 to $9.84 a share, up from $9.63 to $9.83 a share.Shares advanced 2.4% to $195 in premarket trading.For the third quarter, the Secaucus, N.J., company posted a profit of $245 million, or $2.16 a share, compared with $226 million, or $1.99 a share, in the same quarter a year earlier.Stripping out one-time items, adjusted earnings were $2.60 a share, topping analyst forecasts by a dime, according to FactSet.Revenue jumped 13% to $2.82 billion, ahead of analyst estimates for $2.74 bill","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1854103824.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) INC","BK4196":"保健护理服务","BK4588":"碎股","LU1854104046.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) ACC","BK4583":"猴痘概念","BK4585":"ETF&股票定投概念","BK4567":"ESG概念","DGX":"奎斯特诊疗"},"translate_title":"Quest Diagnostics提高有机增长指导","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DGX":1.5},"content_text":"By Dean Seal \n\n\n \n\n\n  Quest Diagnostics raised its profit and revenue outlook for the year after strong organic growth and acquisitions boosted its top and bottom lines in the third quarter. \n\n\n  The provider of diagnostic information services said Tuesday that organic revenue growth in the latest completed quarter hit 6.8%, while acquisitions boosted the top line higher. \n\n\n  Quest is now guiding for $10.96 billion to $11 billion in revenue for 2025, up from a prior outlook for $10.8 billion to $10.92 billion, and adjusted earnings of $9.76 to $9.84 a share, up from $9.63 to $9.83 a share. \n\n\n  Shares advanced 2.4% to $195 in premarket trading. \n\n\n  For the third quarter, the Secaucus, N.J., company posted a profit of $245 million, or $2.16 a share, compared with $226 million, or $1.99 a share, in the same quarter a year earlier. \n\n\n  Stripping out one-time items, adjusted earnings were $2.60 a share, topping analyst forecasts by a dime, according to FactSet. \n\n\n  Revenue jumped 13% to $2.82 billion, ahead of analyst estimates for $2.74 billion. \n\n\n  During the quarter, Quest completed the acquisition of select dialysis testing assets from Fresenius Medical Care and separately began to scale clinical lab testing for Fresenius Medical Care's U.S. dialysis customers. \n\n\n \n\n\n  Write to Dean Seal at dean.seal@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 21, 2025 07:12 ET (11:12 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}